Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1036644.RA3fuFZr7fO2Rkb0-Slb7IpsA1QiZTLBzVmxrbYAQ98SI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1036644.RA3fuFZr7fO2Rkb0-Slb7IpsA1QiZTLBzVmxrbYAQ98SI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1036644.RA3fuFZr7fO2Rkb0-Slb7IpsA1QiZTLBzVmxrbYAQ98SI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1036644.RA3fuFZr7fO2Rkb0-Slb7IpsA1QiZTLBzVmxrbYAQ98SI130_provenance.
- NP1036644.RA3fuFZr7fO2Rkb0-Slb7IpsA1QiZTLBzVmxrbYAQ98SI130_assertion description "[Part II of this continuing medical education article will discuss the treatment options for stage IV melanoma, including novel therapies, such as ipilimumab and vemurafenib; established therapies, including high-dose interleukin-2, conventional chemotherapy, and biochemotherapy; and additional therapies currently under investigation in the form of clinical trials.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1036644.RA3fuFZr7fO2Rkb0-Slb7IpsA1QiZTLBzVmxrbYAQ98SI130_provenance.
- NP1036644.RA3fuFZr7fO2Rkb0-Slb7IpsA1QiZTLBzVmxrbYAQ98SI130_assertion evidence source_evidence_literature NP1036644.RA3fuFZr7fO2Rkb0-Slb7IpsA1QiZTLBzVmxrbYAQ98SI130_provenance.
- NP1036644.RA3fuFZr7fO2Rkb0-Slb7IpsA1QiZTLBzVmxrbYAQ98SI130_assertion SIO_000772 23244384 NP1036644.RA3fuFZr7fO2Rkb0-Slb7IpsA1QiZTLBzVmxrbYAQ98SI130_provenance.
- NP1036644.RA3fuFZr7fO2Rkb0-Slb7IpsA1QiZTLBzVmxrbYAQ98SI130_assertion wasDerivedFrom befree-2016 NP1036644.RA3fuFZr7fO2Rkb0-Slb7IpsA1QiZTLBzVmxrbYAQ98SI130_provenance.
- NP1036644.RA3fuFZr7fO2Rkb0-Slb7IpsA1QiZTLBzVmxrbYAQ98SI130_assertion wasGeneratedBy ECO_0000203 NP1036644.RA3fuFZr7fO2Rkb0-Slb7IpsA1QiZTLBzVmxrbYAQ98SI130_provenance.
- befree-2016 importedOn "2016-02-19" NP1036644.RA3fuFZr7fO2Rkb0-Slb7IpsA1QiZTLBzVmxrbYAQ98SI130_provenance.